Current immunotherapy in gastrointestinal malignancies A Review

Area of Science:

• Oncology
• Immunology

Background:

• Traditional cancer therapies (surgery, chemotherapy, radiation) often lack specificity.
• Cancer immunotherapy stimulates or suppresses the immune system to target cancer cells.
• Immunotherapy offers high specificity for tumor-specific antigens, differentiating it from conventional treatments.

Purpose of the Study:

• To review approved immunotherapy agents for gastrointestinal (GI) cancers.
• To discuss the current and future role of immunotherapy in treating GI malignancies.

Main Methods:

• Literature review of immunotherapy agents for GI cancers.
• Analysis of approved agents by regulatory bodies like the US Food and Drug Administration.
• Discussion of clinical trial outcomes and future therapeutic strategies.

Main Results:

• Immunotherapy has shown significant promise in treating various cancers.
• Several immunotherapy agents are approved for multiple cancer types.
• The application of immunotherapy in GI cancers is particularly encouraging for advanced or refractory cases.

Conclusions:

• Cancer immunotherapy represents a revolutionary treatment modality with high specificity.
• Approved immunotherapies are transforming the treatment landscape for GI cancers.
• Future research will likely expand the use of immunotherapy in managing GI malignancies.